Scientists identify molecule driving one of the deadliest forms of breast cancer
Australian researchers have uncovered a promising new way to tackle one of the most aggressive forms of breast…
Glioma microenvironment emerges as key target for future therapies
The prognosis for glioma patients remains extremely poor despite aggressive multimodal standard therapy: maximal safe resection, radiotherapy, and…
Würzburg researchers discover alternative approach to preventing thrombosis
Glycoprotein VI, or GPVI for short, is a surface receptor found exclusively on platelets and their precursor cells,…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
A common dietary nutrient feeds a gut pathway linked to atrial fibrillation
A 5,090-person cohort and complementary mouse experiments trace how a diet-linked microbial pathway could reshape atrial structure, electrical…
Cambridge scientists solve brain puzzle behind popular obesity drugs
Cambridge scientists have solved the mystery of why both stimulating and blocking a particular ‘switch’ in the brain…
Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits
A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
Thymulin curbs age-related inflammation and slows breast tumors in mice
A thymus-derived peptide reduced inflammatory immune activity and improved immunotherapy responses in aged mice, suggesting a potential strategy…
GLP-1 receptor agonists may increase hair loss risk
Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased…
Early electroacupuncture intervention protects pancreatic function in prediabetes
Prediabetes refers to a metabolic state in which blood glucose is higher than normal but has not yet…
Popular diabetes drugs do not alter the risk of developing a blinding eye condition
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – a type of…
Researchers identify immune cell receptor that drives organ aging process
We may age at different rates, but none of us escapes aging. A study in mice and in…